AVCNF - CBD-Focused Avicanna Announces Funding Boost For Research And Development | Benzinga
Cannabinoid-based biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Monday that it has closed a non-brokered private placement offering of 2,537,508 units of the company at $0.35 per unit for aggregate gross proceeds of $888,127.80.
The Details
Each unit is comprised of one common share in the capital of the company and one-half of one common share purchase warrant of the company. Each warrant shall entitle the holder thereof to acquire one common share in the capital of the company at an exercise price of $0.41 ...